78965-35-2Relevant articles and documents
SULFONIMIDAMIDE COMPOUNDS AS NLRP3 MODULATORS
-
Paragraph 1010; 1011, (2021/07/31)
Described herein are compounds of Formula (I), Formula (I-A), and Formula (I-B), solvates thereof, tautomers thereof, and pharmaceutically acceptable salts of the foregoing, Further described herein are methods of inhibiting NLRP3 using said compounds, and methods of and compositions useful in treating NLRP3-dependent disorders.
SULFONAMIDE DERIVATIVES AND USES THEREOF
-
Paragraph 0917, (2020/12/30)
The present disclosure relates to compounds of Formula (I) or (II): and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in the treatment of disorders in which inflammasome activity is implicated, such as inflammatory, autoinflammatory and autoimmune diseases and cancers.
A Novel Synthesis of Benzodicyclobutene via a Dual Parham Cyclialkylation
Bradsher, Charles K.,Hunt, David A.
, p. 4608 - 4610 (2007/10/02)
-
